Correlation between PDZK1, Cdc37, Akt and breast cancer malignancy: The role of PDZK1 in cell growth through Akt stabilization by increasing and interacting with Cdc37

Molecular Medicine

Volumn 20, Issue 1, 2014, Pages 270-279

  Kim, Hogyoung ^a   Abd Elmageed, Zakaria Y ^b   Davis, Christian ^a   El Bahrawy, Ali H ^a   Naura, Amarjit S ^a   Ekaidi, Ibrahim ^c   Abdel Mageed, Asim B ^b   Boulares, A Hamid ^a  

^a LOUISIANA STATE UNIVERSITY HEALTH SCIENCES CENTER   (United States)

^b TULANE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c SOUTHERN UNIVERSITY AT NEW ORLEANS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CELL CYCLE PROTEIN 37; CYCLIN D1; EPIDERMAL GROWTH FACTOR RECEPTOR; EPIDERMAL GROWTH FACTOR RECEPTOR 2; ESTRADIOL; ETOPOSIDE; FLUOROURACIL; GROWTH PROMOTOR; HEAT SHOCK PROTEIN 90; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE 1; PACLITAXEL; PDZ PROTEIN; PROTEIN KINASE B; PROTEIN PDZK1; SOMATOMEDIN; UNCLASSIFIED DRUG; MITOGEN ACTIVATED PROTEIN KINASE 3; SCAFFOLD PROTEIN; CARRIER PROTEIN; CDC37 PROTEIN, HUMAN; CELL CYCLE PROTEIN; CHAPERONIN; PDZK1 PROTEIN, HUMAN;

ANCHORAGE INDEPENDENT GROWTH; ARTICLE; BREAST CANCER; BREAST CARCINOGENESIS; CONCENTRATION RESPONSE; CORRELATION ANALYSIS; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; MCF 7 CELL LINE; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; PROTEIN STABILITY; SIGNAL TRANSDUCTION; TISSUE MICROARRAY; UBIQUITINATION; CANCER GROWTH; CANCER RESISTANCE; CELL GROWTH; CONTROLLED STUDY; DISEASE ASSOCIATION; ENZYME PHOSPHORYLATION; ENZYME STABILITY; GENE OVEREXPRESSION; PROTEIN FUNCTION; PROTEIN TARGETING; UPREGULATION; BREAST TUMOR; CELL PROLIFERATION; FEMALE; METABOLISM;

BREAST NEOPLASMS; CARRIER PROTEINS; CELL CYCLE PROTEINS; CELL PROLIFERATION; CHAPERONINS; FEMALE; HUMANS; MCF-7 CELLS; PROTO-ONCOGENE PROTEINS C-AKT;

EID: 84904334629     PISSN: 10761551     EISSN: None     Source Type: Journal    
DOI: 10.2119/molmed.2013.00166     Document Type: Article

References (35)

1. Miyoshi Y, Murase K, Saito M, Oh K. (2010) Prediction of hormone sensitivity for breast cancers. Breast Cancer. 17:86-91.
2. Sasano H, Nagasaki S, Miki Y, Suzuki T. (2009) New developments in intracrinology of human breast cancer: estrogen sulfatase and sulfotransferase. Ann. N. Y. Acad. Sci. 1155:76-9.
3. Wang T, You Q, Huang FS, Xiang H. (2009) Recent advances in selective estrogen receptor modulators for breast cancer. Mini Rev. Med. Chem. 9:1191-201.
4. Eroles P, Bosch A, Perez-Fidalgo JA, Lluch A. (2012) Molecular biology in breast cancer: intrinsic subtypes and signaling pathways. Cancer Treat. Rev. 38:698-707.
5. de la Vega M, Diaz-Canton E, Alvarez RH. (2012) Novel targeted agents for the treatment of advanced breast cancer. Future Med. Chem. 4:893-914.
6. Hong DS, et al. (2013) Targeting the molecular chaperone heat shock protein 90 (HSP90): lessons learned and future directions. Cancer Treat. Rev. 39:375-87.
7. Pearl LH. (2005) Hsp90 and Cdc37: a chaperone cancer conspiracy. Curr. Opin. Genet. Dev. 15:55-61.
8. Garcia-Carbonero R, Carnero A, Paz-Ares L. (2013) Inhibition of HSP90 molecular chaperones: moving into the clinic. Lancet Oncol. 14:e358-69.
9. Karnitz LM, Felts SJ. (2007) Cdc37 regulation of the kinome: when to hold 'em and when to fold 'em. Sci. STKE. 2007:pe22.
10. Smith JR, Clarke PA, de Billy E, Workman P. (2009) Silencing the cochaperone CDC37 destabilizes kinase clients and sensitizes cancer cells to HSP90 inhibitors. Oncogene. 28:157-69.
11. Manning BD, Cantley LC. (2007) AKT/PKB signaling: navigating downstream. Cell. 129:1261-74.
12. Yoon MK, Mitrea DM, Ou L, Kriwacki RW. (2012) Cell cycle regulation by the intrinsically disordered proteins p21 and p27. Biochem. Soc. Trans. 40:981-8.
13. Kocher O, Comella N, Tognazzi K, Brown LF. (1998) Identification and partial characterization of PDZK1: a novel protein containing PDZ interaction domains. Lab. Invest. 78:117-25.
14. Kocher O, et al. (2003) Targeted disruption of the PDZK1 gene in mice causes tissue-specific depletion of the high density lipoprotein receptor scavenger receptor class B type I and altered lipoprotein metabolism. J. Biol. Chem. 278:52820-5.
15. Ghosh MG, Thompson DA, Weigel RJ. (2000) PDZK1 and GREB1 are estrogen-regulated genes expressed in hormone-responsive breast cancer. Cancer Res. 60:6367-75.
16. Dunbier AK, et al. (2010) Relationship between plasma estradiol levels and estrogen-responsive gene expression in estrogen receptor-positive breast cancer in postmenopausal women. J. Clin. Oncol. 28:1161-7.
17. Kim H, et al. (2013) PDZK1 is a novel factor in breast cancer that is indirectly regulated by estrogen through IGF-1R and promotes estrogenmediated growth. Mol. Med. 19:253-62.
18. Zerfaoui M, et al. (2010) Poly(ADP-ribose) polymerase-1 is a determining factor in Crm1-mediated nuclear export and retention of p65 NF-kappa B upon TLR4 stimulation. J. Immunol. 185:1894-902.
19. Flowers JL, et al. (1986) Use of monoclonal antiestrogen receptor antibody to evaluate estrogen receptor content in fine needle aspiration breast biopsies. Ann. Surg. 203:250-4.
20. Freudenberg JA, et al. (2009) The role of HER2 in early breast cancer metastasis and the origins of resistance to HER2-targeted therapies. Exp. Mol. Pathol. 87:1-11.
21. Renoir JM, Marsaud V, Lazennec G. (2013) Estrogen receptor signaling as a target for novel breast cancer therapeutics. Biochem. Pharmacol. 85:449-65.
22. Moulder SL. (2010) Does the PI3K pathway play a role in basal breast cancer? Clin. Breast Cancer. 10 (Suppl. 3):S66-71.
23. Agelaki S, et al. (2009) Caveolin-1 regulates EGFR signaling in MCF-7 breast cancer cells and enhances gefitinib-induced tumor cell inhibition. Cancer Biol. Ther. 8:1470-7.
24. Basso AD, et al. (2002) Akt forms an intracellular complex with heat shock protein 90 (Hsp90) and Cdc37 and is destabilized by inhibitors of Hsp90 function. J. Biol. Chem. 277:39858-66.
25. Solit DB, Basso AD, Olshen AB, Scher HI, Rosen N. (2003) Inhibition of heat shock protein 90 function down-regulates Akt kinase and sensitizes tumors to Taxol. Cancer Res. 63:2139-44.
26. Panaretou B, et al. (2002) Activation of the ATPase activity of hsp90 by the stress-regulated cochaperone aha1. Mol. Cell. 10:1307-18.
27. Barrett T, et al. (2007) NCBI GEO: mining tens of millions of expression profiles-database and tools update. Nucleic Acids Res. 35:D760-5.
28. Boersma BJ, et al. (2008) A stromal gene signature associated with inflammatory breast cancer. Int. J. Cancer. 122:1324-32.
29. Iwamoto T, et al. (2011) Gene pathways associated with prognosis and chemotherapy sensitivity in molecular subtypes of breast cancer. J. Natl. Cancer Inst. 103:264-72.
30. Kocher O, Krieger M. (2009) Role of the adaptor protein PDZK1 in controlling the HDL receptor SR-BI. Curr. Opin. Lipidol. 20:236-41.
31. Hu S, et al. (2009) Systematic analysis of a simple adaptor protein PDZK1: ligand identification, interaction and functional prediction of complex. Cell. Physiol. Biochem. 24:231-42.
32. Yu Q, et al. (2006) Requirement for CDK4 kinase function in breast cancer. Cancer Cell. 9:23-32.
33. Wang H, et al. (2008) IGFBP2 and IGFBP5 overexpression correlates with the lymph node metastasis in T1 breast carcinomas. Breast J. 14:261-7.
34. Kocher O, et al. (2008) Influence of PDZK1 on lipoprotein metabolism and atherosclerosis. Biochim. Biophys. Acta. 1782:310-6.
35. Inoue J, et al. (2004) Overexpression of PDZK1 within the 1q12-q22 amplicon is likely to be associated with drug-resistance phenotype in multiple myeloma. Am. J. Pathol. 165:71-81.